Invus
New York City, New Yorkinvus.com
Overview
Invus is a global, evergreen equity investment firm founded in 1985 that manages over $10 billion. It partners with entrepreneurs and management teams to transform their industries. The firm's capital originates from a European family group, and it does not raise outside funds, allowing for a long-term investment horizon. Invus invests across various stages, including venture capital, growth/expansion, and private equity buyouts, in sectors such as consumer goods and services, biotech, medical devices, and software.
Portfolio Companies
97
Website
invus.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| City Therapeutics | Jun 2026 | Series B | Co-investor |
| Contraline | Jun 2026 | Series B | Co-investor |
| Oqc Tech | Jun 2026 | Series C | Co-investor |
| Ray Therapeutics | Apr 2026 | Series B | Co-investor |
| Flexiv | Mar 2026 | Strategic | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.